Table 1 Demographic data

From: A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen

No. of patients (%): 51(100)

 

Age (years)

 

 Median

63

 Range

(42–81)

Karnofsky performance status

 

 100

12 (24)

 90

16 (31)

 80

22 (43)

 70

1 (2)

 Males

41 (80)

 Females

10 (20)

Stage at diagnosis

 

 Unknown

11 (22)

 0IS

1 (2)

 I

5 (10)

 II

3 (6)

 III

8 (16)

 IV

23 (45)

Number of organs involved

 

 1

20 (39)

 2

19 (37)

3

12 (24)

 Lung only

7 (13.7)

 Liver only

6 (11.8)

 Bone only

1 (2.0)

 Lymph nodes

34 (66.7)

 Skin

2 (3.9)

 Soft tissues

8 (15.7)

 Lung+liver

9 (17.6)

 Lung+bone

1 (2.0)

 Liver+bone

2 (3.9)

 Other organs

12 (23.5)